Psoriasis (Q56115291)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Psoriasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Wolf-Henning Boehncke

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Michael P Schön

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

27 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

9997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

983-994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

Psoriasis causes as much disability as other major medical diseases

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis--epidemiology and clinical spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Epidemiology and comorbidity of psoriasis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

1 reference

7 January 2021

Latitude and psoriasis prevalence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Effect of weather and environmental factors on the clinical course of psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Pathogenesis and clinical features of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

1 reference

7 January 2021

The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Scalp psoriasis: European consensus on grading and treatment algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Approach to managing patients with nail psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The Burden of Nail Psoriasis: An Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

1 reference

7 January 2021

The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

How Great Is the Risk of Further Psoriasis Following a Single Episode of Acute Guttate Psoriasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Management of psoriasis in adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The role of drugs in the induction and/or exacerbation of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Triggering psoriasis: the role of infections and medications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Managing comorbid disease in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Immunopathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Immunopathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Molecular dissection of psoriasis: integrating genetics and biology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The IL-23/Th17 axis in the immunopathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

IL-23: a master regulator in Crohn disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

T(H)-17 cells in the circle of immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The plot thickens while the scope broadens: a holistic view on IL-17 in psoriasis and other inflammatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Innate immunity and antimicrobial defense systems in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Angiogenesis and chronic inflammation: cause or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Upregulation of hypoxia-inducible factors in normal and psoriatic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Regulatory T cells control VEGF-dependent skin inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Angiogenesis: the new potential target for the therapy of psoriasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Nerve-derived transmitters including peptides influence cutaneous immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The concept of psoriasis as a systemic inflammation: implications for disease management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The natural history of psoriasis in 5,600 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis and other complex trait dermatoses: from Loci to functional pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Cellular Genomic Maps Help Dissect Pathology in Human Skin Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Genetic Analysis of PSORS1 Distinguishes Guttate Psoriasis and Palmoplantar Pustulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Association of Interleukin 23 Receptor Variants with Psoriatic Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Biomarkers in psoriasis and psoriatic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Pharmacogenetics of psoriasis:HLA-Cw6but notLCE3B/3Cdeletion norTNFAIP3polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Disease concomitance in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The Risk of Lymphoma in Patients with Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis: a possible risk factor for development of coronary artery calcification.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Complexity of the association between psoriasis and comorbidities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Consensus guidelines for the management of plaque psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Secukinumab in plaque psoriasis--results of two phase 3 trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Topical treatments for chronic plaque psoriasis of the scalp: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Definition of treatment goals for moderate to severe psoriasis: a European consensus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Interventions for nail psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis and risk of cardiovascular disease: a meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Recommendations for detection of individual risk for comorbidities in patients with psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriatic arthritis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Research gaps in psoriasis: opportunities for future studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Predicting the unpredictable: autoantibody profile as parameter to foretell individual responses to infliximab treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Antidrug antibodies in psoriasis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis clinical implications and treatment: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Animal models of psoriasis: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Endothelial cells are highly heterogeneous at the level of cytokine-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961909-7

7 January 2021

10.1016/S0140-6736(14)61909-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26025581%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference